Conservative treatment of superficial transitional cell carcinoma of prostatic urethra with intravesical BCG

Complications of Bacillus Calmette-Guerin Immunotherapy in 1,278 Patients with Bladder Cancer

1986 • 394 citations

Bacillus Calmette-Guerin Immunotherapy for Bladder Cancer

1985 • 300 citations

Long-Term Effect of Intravesical Bacillus Calmette-Guerin on Flat Carcinoma in Situ of the Bladder

1986 • 233 citations

Prostatic Involvement by Transitional Cell Carcinoma: Pathogenesis, Patterns and Prognosis

1977 • 163 citations

Two Courses of Intravesical Bacillus Calmette-Guerin for Transitional Cell Carcinoma of the Bladder

1986 • 108 citations

Prognostic Value of Purified Protein Derivative Skin Test and Granuloma Formation in Patients Treated with Intravesical Bacillus Calmette-Guerin

1986 • 101 citations

Toxicity of intravesical BCG and its management in patients with superficial bladder tumors

1987 • 97 citations

Ureteral Carcinoma in Situ After Successful Intravesical Therapy for Superficial Bladder Tumors: Incidence, Possible Pathogenesis and Management

1987 • 90 citations

Intravesical administration of bacillus Calmette-Guérin in patients with recurrent superficial carcinoma of the urinary bladder: report of a prospective, randomized trial.

1985 • 88 citations

Durable Response of a Carcinoma in Situ of the Renal Pelvis to Topical Bacillus Calmette-Guerin

1985 • 79 citations

Superficial Transitional Cell Carcinoma of the Bladder Associated with Mucosal Involvement of the Prostatic Urethra: Results of Treatment with Intravesical Bacillus Calmette-Guerin

1988 • 69 citations